Literature DB >> 29301443

Softened food reduces weight loss in the streptozotocin-induced male mouse model of diabetic nephropathy.

Sisse A Nørgaard1,2,3, Fredrik W Sand1, Dorte B Sørensen2, Klas Sp Abelson4, Henrik Søndergaard3.   

Abstract

The streptozotocin (STZ)-induced diabetic mouse is a widely used model of diabetes and diabetic nephropathy (DN). However, it is a well-known issue that this model is challenged by high weight loss, which despite supportive measures often results in high euthanization rates. To overcome these issues, we hypothesized that supplementing STZ-induced diabetic mice with water-softened chow in addition to normal chow would reduce weight loss, lower the need for supportive treatment, and reduce the number of mice reaching the humane endpoint of 20% weight loss. In a 15 week STZ-induced DN study we demonstrated that diabetic male mice receiving softened chow had reduced acute weight loss following STZ treatment ( p = 0.045) and additionally fewer mice were euthanized due to weight loss. By supplementing the diabetic mice with softened chow, no mice reached 20% weight loss whereas 37.5% of the mice without this supplement reached this humane endpoint ( p = 0.0027). Excretion of corticosterone metabolites in faeces was reduced in diabetic mice on softened chow ( p = 0.0007), suggesting lower levels of general stress. Finally, it was demonstrated that the water-softened chow supplement did not significantly affect the induction of key disease parameters, i.e. %HbA1C and albuminuria nor result in abnormal teeth wear. In conclusion, supplementation of softened food is refining the STZ-induced diabetic mouse model significantly by reducing stress, weight loss and the number of animals sacrificed due to humane endpoints, while maintaining the key phenotypes of diabetes and nephropathy.

Entities:  

Keywords:  diabetic nephropathy; reduction; refinement; streptozotocin-induced diabetes; weight loss

Mesh:

Substances:

Year:  2018        PMID: 29301443     DOI: 10.1177/0023677217747915

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  4 in total

1.  Foretinib mitigates cutaneous nerve fiber loss in experimental diabetic neuropathy.

Authors:  Gregory H Borschel; Konstantin Feinberg; Simeon C Daeschler; Jennifer Zhang; Tessa Gordon
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

2.  Bone Marrow Endothelial Cells Regulate Myelopoiesis in Diabetes Mellitus.

Authors:  Friedrich Felix Hoyer; Xinyi Zhang; Partha Dutta; Matthias Nahrendorf; Emilie Coppin; Sathish Babu Vasamsetti; Ganesh Modugu; Maximilian J Schloss; David Rohde; Cameron S McAlpine; Yoshiko Iwamoto; Peter Libby; Kamila Naxerova; Filip K Swirski
Journal:  Circulation       Date:  2020-04-22       Impact factor: 29.690

3.  Knockout of NGAL aggravates tubulointerstitial injury in a mouse model of diabetic nephropathy by enhancing oxidative stress and fibrosis.

Authors:  Xiaoli Liu; Xincheng Zhao; Xiaoting Duan; Xiaoying Wang; Taoxia Wang; Shuning Feng; Huifang Zhang; Cheng Chen; Guiying Li
Journal:  Exp Ther Med       Date:  2021-02-05       Impact factor: 2.447

4.  Intracavernous Injection of Platelet-Rich Plasma Therapy Enhances Erectile Function and Decreases the Mortality Rate in Streptozotocin-Induced Diabetic Rats.

Authors:  Chun-Hou Liao; Kau-Han Lee; Shiu-Dong Chung; Kuo-Chiang Chen; Chellappan Praveen Rajneesh; Bo-He Chen; Jai-Hong Cheng; Wang-Ying Lin; Han-Sun Chiang; Yi-No Wu
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.